PERSPECTIVES IN BIOLOGY AND MEDICINE, published by the esteemed Johns Hopkins University Press, has been a cornerstone of interdisciplinary dialogue since its inception in 1957. With a rich history spanning over six decades, this journal delves into the multifaceted interactions between biology and medicine, offering insights that are vital for health policy, ethics, and the philosophy of science. Recognized for its impact, it holds a Q2 ranking in the History and Philosophy of Science category and Q3 rankings in several other relevant fields as of 2023. While not an open-access publication, it provides critical analyses and discussions that are indispensable for researchers, professionals, and students alike. With its committed editorial team, PERSPECTIVES IN BIOLOGY AND MEDICINE continues to foster scholarly engagement and is poised to shape the future discourse in the biosciences.

JAMA - Journal of the American Medical Association, published by the American Medical Association, stands as a leading voice in the field of medicine, with an impressive impact factor that reflects its status as a pivotal resource for health professionals. Established in 1883, JAMA has consistently evolved to meet the changing landscape of medical research and practice, converging its insights into the realm of general medicine through to 2024. As a Q1 journal in the Medicine (miscellaneous) category, JAMA ranks notably at #6 out of 636 in Scopus, placing it within the 99th percentile of its field. Although it does not currently offer open access options, JAMA remains a critical platform for disseminating groundbreaking research and clinical studies, facilitating engagement among researchers, healthcare professionals, and students alike. Its commitment to advancing health knowledge makes it an indispensable asset for anyone dedicated to the pursuit of excellence in medical science.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

The Journal of Bioethical Inquiry, published by Springer, is a prominent academic journal in the fields of bioethics, health policy, and social sciences. Established in 2004 and running through 2024, it is recognized for providing a critical platform for the exploration of ethical issues arising in the contexts of healthcare and policy making. With an ISSN of 1176-7529 and an E-ISSN of 1872-4353, this esteemed journal holds a Q2 quartile ranking in both Health Policy and Health (Social Science) categories, indicating its significant impact and contributions to the field. It boasts impressive Scopus rankings, with a standing of #70 out of 371 in Social Sciences _ Health (Social Science) and #68 out of 310 in Medicine _ Health Policy, representing its relevance and authority in these domains. Although it does not currently offer open access options, the Journal of Bioethical Inquiry remains a vital resource for researchers, practitioners, and students eager to engage with the complexities of bioethical challenges and to advance the discourse on health policies.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

The Archives of Hellenic Medicine is a distinguished academic journal published by the ATHENS MEDICAL SOC, dedicated to advancing the field of general medicine. Since its inception in 1997 and spanning until 2024, this journal has established itself as a vital platform for disseminating innovative research and clinical insights within the medical community. Despite currently holding a Q4 ranking in the broad field of Medicine (miscellaneous) and a rank of #546 out of 636 in general medicine, it provides an essential forum for emerging scholars and seasoned professionals alike. With its roots in Greece, the journal aims to bridge the gap between research and practice through accessible content that enhances healthcare delivery. While the journal does not follow an open access model, it remains a key resource for researchers, professionals, and students looking to enrich their understanding of contemporary medical issues and advancements.

Welcome to the McGill Journal of Law and Health, a distinguished publication that uniquely intersects the fields of law and health policy, published by McGill University, Faculty of Law. Operating from the vibrant city of Montreal, Canada, this journal serves as a vital forum for scholars, practitioners, and students who are passionate about exploring the intricate relationship between legal frameworks and health systems. With an ISSN of 1920-4825, the journal encapsulates a rigorous approach to examining pressing legal issues affecting public health and is committed to advancing knowledge and discussion within its scope. Ranked within the Q3 category in Law and Q4 in Health Policy for 2023, it is positioned to facilitate significant contributions to both academic and practical landscapes. It features an array of research articles, case studies, and policy analyses that are freely accessible, fostering an inclusive environment for knowledge-sharing. The McGill Journal of Law and Health is an essential resource for those aiming to engage with contemporary debates and findings at the intersection of law and health, offering insights that are crucial for informed decision-making and advocacy in this evolving field.

Monash Bioethics Review, published by SPRINGER HEIDELBERG, is a leading journal in the interdisciplinary realm of bioethics, dedicated to exploring critical issues at the intersection of health policy, philosophy, and the social sciences. With an impressive impact factor placing it in Q1 in Philosophy and notable rankings across disciplines, including Q3 in Health Policy and Medicine, it serves as an essential platform for researchers, professionals, and students alike. This journal not only aims to foster robust discourse on ethical dilemmas but also seeks to contribute to policymaking through rigorous analysis and research. Covering articles from its inception in 1994 to the present, Monash Bioethics Review remains committed to addressing contemporary ethical challenges in medicine and society, making it a vital resource for those keen on navigating the complexities of bioethical thought.

Asian Bioethics Review, published by SPRINGER, is a premier journal indexed with ISSN 1793-8759 and E-ISSN 1793-9453, dedicated to advancing discourse in the interdisciplinary field of bioethics across Asia and beyond. Established in 2015, this esteemed publication has rapidly gained recognition, achieving a Q1 ranking in Philosophy and Q2 in key categories such as Health Policy and Issues, Ethics and Legal Aspects in 2023. With its robust Scopus rankings highlighting its significance across diverse domains—including a remarkable 98th percentile ranking in Philosophy—the journal serves as a vital platform for researchers, ethicists, and policymakers to explore pressing ethical issues and contribute to policy development in health and social sciences. Although not open access, the journal ensures a wide reach through institutional subscriptions, making it an essential resource for students and professionals committed to ethical practices in healthcare. Set in the dynamic backdrop of Singapore, "Asian Bioethics Review" continues to shape the conversation around bioethical practices in the Asian context and globally.

CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS is a premier journal published by Cambridge University Press, focusing on significant issues at the intersection of healthcare, ethics, and policy. With an ISSN of 0963-1801 and an E-ISSN of 1469-2147, this journal serves as a vital platform for discourse among researchers, practitioners, and scholars in the health social sciences. Emphasizing vital ethical considerations in healthcare practices and policies, it ranks in the Q3 tier for Health Policy and Q2 for both Health (Social Science) and Issues, Ethics, and Legal Aspects according to the 2023 journal category quartiles. The journal, spanning its tenure from 1992 to 2024, features rigorous peer-reviewed articles that contribute to the advancement of ethical standards in healthcare. By addressing contemporary ethical dilemmas and promoting scholarly dialogue, CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS remains an essential resource for those committed to understanding the complexities and ethical implications inherent in health systems today.